시장보고서

상품코드

1906688

색전 코일 시장 규모와 예측(2021-2031년) - 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 코일 유형별, 용도별, 최종사용자별, 지역별

Embolization Coils Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Coils, Application, End User, and Geography

발행일: 2025년 12월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 199 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

색전 코일 시장 규모는 2024년 18억 7,000만 달러에서 2031년까지 36억 8,000만 달러로 성장할 이를 것으로 예측되며, 2025-2031년 연평균 복합 성장률(CAGR) 10.2%를 보일 것으로 예측됩니다. 혈관 질환 및 동맥류 유병률 증가, 최소 침습 수술에 대한 수요 증가, 고령화 사회 등의 요인이 색전 코일 시장 규모 확대에 기여하는 주목할 만한 요소로 꼽힙니다. 또한, 차세대 색전 재료의 개발로 인해 가까운 미래에 새로운 색전 코일 시장의 트렌드가 형성될 것으로 예측됩니다.

차세대 색전 재료는 저침습수술 정도, 생체 적합성, 장기적인 유효성을 향상시킵니다.기존 백금 코일은 재소통이나 불완전 폐쇄라고 하는 과제를 극복하기 위해, 하이드로겔, 생체 활성 폴리머, 형상기억합금을 조합한 첨단하이브리드 제품으로 진화를 이루고 있습니다.실제, EMBOLD 파이바데탓체브르코일은 섬유 구조에 의해 혈전 형성을 촉진해, 말초혈관 혈류를 감소시키는 우수한 사례입니다. 또한 복잡한 해부학적 구조에서도 충전 밀도를 최대화하기 위해(때문에), 전개시 이동 리스크를 최소한으로 억제합니다.

약물 용출형 코일도 이 분야의 새로운 발명품으로, 파클리탁셀이나 실로리무스 등의 생물학적 활성 물질을 내장하여 재협착을 방지합니다. 말초동맥 색전술에서 이 코일을 사용한 연구에 따르면, 백금 코일을 사용하지 않은 경우와 비교했을 때 표적 병변의 재혈관화율이 25% 감소하는 것으로 나타났습니다. 마찬가지로 형상기억합금과 섬유형 백금 코일도 충진 밀도를 높입니다. 섬유질 디자인은 혈전 형성을 촉진하여 혈전 형성을 촉진하여 상당히 높은 즉각적인 폐색률을 달성합니다. 2023년에는 하이드로겔 코팅 코일이 등장하여 응고 효율이 30% 향상되고 생체적합성이 향상되어 생체 내 염증반응이 감소했습니다.

종양학 분야에서는 약물 용출형 코일이 화학요법의 국소적 전달을 실현하여 간세포암 환자의 무진행 생존기간을 기존 방식에 비해 40% 연장시켰습니다. 이러한 기술은 시술 시간을 단축할 뿐만 아니라 외래 진료 환경으로의 전환을 촉진하고 환자 중심의 의료에 부합하는 기술입니다. 연구개발에 대한 투자가 증가함에 따라 형상기억성 하이드로겔의 조합으로 완전 적응형 코일의 개발이 기대되고 있습니다. 이는 2031년까지 폐색 내구성에 큰 영향을 미쳐 비뇨기과 및 심장학 분야에서의 적용 확대가 예상되며, 색전 코일 시장의 중요한 트렌드로 부상할 것으로 보입니다.

최종 사용자별 인사이트

최종 사용자별로 색전 코일 시장은 병원, 외래진료센터, 기타로 분류됩니다. 2024년 기준 병원 부문이 가장 큰 시장 점유율을 차지했습니다. 병원은 뇌동맥류, 동정맥기형(AVM), 종양 관련 색전술 등 혈관질환의 진단 및 치료의 핵심 시설이기 때문에 전 세계적으로 코일 설치의 주요 수행 장소가 되고 있습니다. 예를 들어, 신경학 분야에서는 병원 카테터 검사실에서 중재적 방사선사가 뇌동맥류가 파열되어 뇌졸중을 유발할 수 있는 뇌동맥류 파열을 피하기 위해 탈착식 백금 코일을 사용하여 뇌동맥류를 폐쇄하고 있습니다. 이 시술은 미국에서 연간 200만 건 이상의 복부 대동맥류 치료를 통해 입증된 사실이며, 이는 미국 혈관학회에서 보고한 사실입니다. 이 분야의 성장은 서로 밀접하게 연관된 여러 요인에 기인합니다. 고혈압, 당뇨병 등 생활습관병 증가는 심혈관 질환의 위험을 증가시키고 있으며, 이는 저침습적 중재치료에 대한 수요 증가의 주요 원인으로 작용하고 있습니다. 한편, 병원의 최첨단 영상 진단 시스템(예: 투시 장비)과 다직종 팀에 의해 코일을 매우 정밀하게 배치할 수 있어 개복 수술에 비해 위험성이 크게 감소했습니다. 한편, 회복 기간을 단축하고 위험을 줄일 수 있는 혈관 내 치료 기술의 대규모 도입으로 시술 횟수가 눈에 띄게 증가하고 있습니다. 예를 들어, 혈관을 막는 것뿐만 아니라 혈전 형성을 촉진하는 생체 활성 코일의 도입과 같은 기술적 발전은 효과 면에서 큰 개선을 가져왔습니다. 암 치료에서는 간세포암 등 종양으로 가는 혈류를 차단하는 경동맥 화학색전술(CAE)에 코일을 활용하는 방식은 병원이 혁신 치료의 중심지임을 보여주는 좋은 예라고 할 수 있습니다. 따라서 신흥 시장의 의료비 지출 증가와 전 세계 고령화로 인해 그 확대는 더욱 가속화되고 있으며, 병원은 중증 환자를 위한 확장 가능한 색전술 서비스를 제공하는 필수적인 거점으로 자리매김하고 있습니다. 이는 색전 코일 시장의 성장을 가속하고 있습니다.

색전 코일 시장-주요 시장 역학
시장 성장 촉진요인
- 혈관 질환 및 동맥류 유병률 증가
- 저침습수술에 대한 수요 급증
- 고령화가 진행되는 것으로 저침습색전 코일 도입이 촉진된다
시장 성장 억제요인
- 고가의 기기 및 시술 비용이 보급을 방해한다
- 합병증 리스크가 바람직하지 않은 결과를 부른다
- 숙련 한 전문가 부족이 혁신 지연을 부른다
시장 기회
- 기술적 진보가 혁신을 촉진해, 임상적 성과를 향상시킵니다
- 신제품 개발과 판매 승인이 기회를 창출
- 개발도상 시장에서의 확대가 시술 건수를 증가시킵니다
향후 동향
- 치료 계획 및 시술에의 AI 통합
- 차세대색전재료 개발
- 개별화·환자 중심 치료 접근에의 이동
성장 촉진요인과 억제요인의 영향

제6장 색전 코일 시장-세계 시장 분석

색전 코일 시장 매출,2021-2031년
색전 코일 시장 예측 분석

제7장 색전 코일 시장 분석-색전 코일별

중추신경계 용도
말초혈관 영역

제8장 색전 코일 시장 분석-용도별

신경학
말초혈관 질환
종양학
비뇨기과
기타

제9장 색전 코일 시장 분석-최종사용자별

병원
외래 진료 센터
기타

제10장 색전 코일 시장-지역 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 아시아태평양 기타 국가
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
남미 및 중남미
- 브라질
- 아르헨티나
- 기타 남미·중앙아메리카 기타 지역

제11장 경쟁 구도

주요 기업별 히트맵 분석
기업 점유율 분석(2024년)

제12장 업계 상황

시장 이니셔티브
인수합병(M&A)
기타 동향

제13장 기업 개요

Medtronic Plc
Cook Medical Holdings LLC
Stryker Corp
Boston Scientific Corp
Terumo Corp
NeuroSafe Medical Co. Ltd
Wallaby Medical
Penumbra Inc.
Balt
INVAMED

제14장 부록

LSH 26.01.22

The embolization coils market size is expected to grow from US$ 1.87 billion in 2024 to US$ 3.68 billion by 2031; it is projected to register a CAGR of 10.2% during 2025-2031. The rising prevalence of vascular disorders and aneurysms, burgeoning demand for minimally invasive procedures, and an aging population are noteworthy factors contributing to the expansion of the embolization coils market size. Additionally, the development of next-generation embolic materials is projected to bring new embolization coils market trends in the near future.

Next-generation embolic materials improve the precision, biocompatibility, and long-term effectiveness of minimally invasive procedures. Traditional platinum coils have been transformed into advanced hybrids, which combine hydrogels, bioactive polymers, and shape-memory alloys to overcome problems such as recanalization and incomplete occlusion. In fact, the EMBOLD Fibered Detachable Coil is an excellent case of the coil being a fibered design that facilitates thrombus formation and thus reduces blood flow in the peripheral vessels. Besides, this coil maximizes packing density in complex anatomies, thus minimizing the risks of migration during deployment.

Drug-eluting coils are one more invention in this field, where bioactive agents like paclitaxel or sirolimus are incorporated to avoid restenosis. Studies with these coils in peripheral artery embolization have demonstrated a 25% decrease in the rate of revascularization of target lesions, compared to the rate for bare platinum counterparts. Similar to that, shape-memory alloys and fibered platinum coils raise packing density; fibered designs achieve significantly higher immediate occlusion rates by promoting thrombus formation. During 2023, hydrogel-coated coils became available; thus, clotting efficiency was raised by 30% and biocompatibility, which leads to fewer inflammatory responses in vivo.

In oncology, drug-eluting coils provide the local delivery of chemotherapy; thus, progression-free survival in hepatocellular carcinoma cases is extended by 40% compared to the conventional methods. These technologies not only decrease the time of the procedure but also facilitate the shift to outpatient settings, which is in line with patient-centric care. With the increasing investments in research and development, the combination of shape-memory hydrogels is expected to result in coils that are fully adaptive and thus, by 2031, will have a great impact on occlusion durability and the widening of application in urology and cardiology fields, thereby emerging as a significant trend in the embolization coils market.

End User-Based Insights

Based on end user, the embolization coils market is segmented into hospitals, ambulatory centers, and others. The hospitals segment held the largest embolization coils market share in 2024. Hospitals are the main places where coil deployments take place worldwide, as they are the central facilities for diagnosing and treating vascular disorders like cerebral aneurysms, arteriovenous malformations (AVMs), and embolizations related to oncology. For example, in neurology, interventional radiologists in hospital catheterization labs employ detachable platinum coils to close off brain aneurysms, thus ruptures that may lead to strokes are avoided-a procedure demonstrated by the treatment of more than 2 million cases of abdominal aortic aneurysm annually in the U.S., which is a fact reported by the vascular societies. This portion's growth is due to a number of factors that are closely related to each other. The increased prevalence of lifestyle-induced diseases such as hypertension and diabetes has led to an increase in cardiovascular risks, which in turn is the main reason for the demand for minimally invasive interventions. On the one hand, hospitals' state-of-the-art imaging systems (for example fluoroscopy) and multidisciplinary teams make it possible for coils to be positioned very precisely, thus, the danger is greatly diminished as compared to open surgery. On the other hand, the large-scale implementation of endovascular techniques-giving the possibility of short recovery time and lessening the risks-has significantly increased the number of procedures performed. To mention a few, the technological advances like the introduction of bioactive coils, which not only close the vessels but also facilitate thrombosis, are a great source of improvement in terms of efficacy. In cancer, the use of transarterial chemoembolization with the help of coils to cut off the blood supply to the tumors, for example, in the case of hepatocellular carcinoma, is definitely a great showcase of how hospitals are the centers for innovative care. Hence, due to increased healthcare spending in emerging markets and the aging global population, the expansion is even greater, and hospitals are thereby positioned as a must for scalable embolization services that cater to patients with high-acuity needs, thereby fueling the embolization coils market growth.

The World Health Organization and Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the embolization coils market report.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Embolization Coils Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Embolization Coils Market - Key Market Dynamics

5.1 Embolization Coils Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Vascular Disorders and Aneurysms
- 5.2.2 Burgeoning Demand for Minimally Invasive Procedures
- 5.2.3 Aging Population Propels Adoption of Minimally Invasive Embolization Coils
5.3 Market Restraints
- 5.3.1 High Device and Procedure Costs Hinder Widespread Adoption
- 5.3.2 Risk of Complications Leads to Unwanted Outcomes
- 5.3.3 Shortage of Skilled Professionals Leads to Delayed Innovation
5.4 Market Opportunities
- 5.4.1 Technological Improvements Drive Innovation and Improve Clinical Outcomes
- 5.4.2 New Product Developments and Marketing Approvals Create Opportunities
- 5.4.3 Expansion in Developing Markets Elevates Procedural Volumes
5.5 Future Trends
- 5.5.1 Integration of AI in Treatment Planning and Procedures
- 5.5.2 Development of Next-Generation Embolic Materials
- 5.5.3 Shift Toward Personalized and Patient-Centric Treatment Approaches
5.6 Impact of Drivers and Restraints:

6. Embolization Coils Market - Global Market Analysis

6.1 Embolization Coils Market Revenue (US$ Million), 2021-2031
6.2 Embolization Coils Market Forecast Analysis

7. Embolization Coils Market Analysis - by Embolization Coils

7.1 Central Application
- 7.1.1 Overview
- 7.1.2 Central Application: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Peripheral Application
- 7.2.1 Overview
- 7.2.2 Peripheral Application: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. Embolization Coils Market Analysis - by Application

8.1 Neurology
- 8.1.1 Overview
- 8.1.2 Neurology: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Peripheral Vascular Disease
- 8.2.1 Overview
- 8.2.2 Peripheral Vascular Disease: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Oncology
- 8.3.1 Overview
- 8.3.2 Oncology: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Urology
- 8.4.1 Overview
- 8.4.2 Urology: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. Embolization Coils Market Analysis - by End User

9.1 Hospital
- 9.1.1 Overview
- 9.1.2 Hospital: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Ambulatory Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Centers: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

10. Embolization Coils Market - Geographical Analysis

10.1 North America
- 10.1.1 North America Embolization Coils Market Overview
- 10.1.2 North America: Embolization Coils Market - Revenue, 2021-2031 (US$ Million)
  - 10.1.2.1 North America: Embolization Coils Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.1.2.2 North America: Embolization Coils Market - Revenue and Forecast Analysis - by Application
  - 10.1.2.3 North America: Embolization Coils Market - Revenue and Forecast Analysis - by End User
- 10.1.3 North America: Embolization Coils Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.1.1 United States: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.1.3.1.2 United States: Embolization Coils Market Breakdown, by Application
    - 10.1.3.1.3 United States: Embolization Coils Market Breakdown, by End User
  - 10.1.3.2 Canada: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.2.1 Canada: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.1.3.2.2 Canada: Embolization Coils Market Breakdown, by Application
    - 10.1.3.2.3 Canada: Embolization Coils Market Breakdown, by End User
  - 10.1.3.3 Mexico: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.3.1 Mexico: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.1.3.3.2 Mexico: Embolization Coils Market Breakdown, by Application
    - 10.1.3.3.3 Mexico: Embolization Coils Market Breakdown, by End User
10.2 Europe
- 10.2.1 Europe Embolization Coils Market Overview
- 10.2.2 Europe: Embolization Coils Market - Revenue, 2021-2031 (US$ Million)
  - 10.2.2.1 Europe: Embolization Coils Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.2.2.2 Europe: Embolization Coils Market - Revenue and Forecast Analysis - by Application
  - 10.2.2.3 Europe: Embolization Coils Market - Revenue and Forecast Analysis - by End User
- 10.2.3 Europe: Embolization Coils Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 Germany: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.1.1 Germany: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.2.3.1.2 Germany: Embolization Coils Market Breakdown, by Application
    - 10.2.3.1.3 Germany: Embolization Coils Market Breakdown, by End User
  - 10.2.3.2 United Kingdom: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.2.1 United Kingdom: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.2.3.2.2 United Kingdom: Embolization Coils Market Breakdown, by Application
    - 10.2.3.2.3 United Kingdom: Embolization Coils Market Breakdown, by End User
  - 10.2.3.3 France: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.3.1 France: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.2.3.3.2 France: Embolization Coils Market Breakdown, by Application
    - 10.2.3.3.3 France: Embolization Coils Market Breakdown, by End User
  - 10.2.3.4 Italy: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.4.1 Italy: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.2.3.4.2 Italy: Embolization Coils Market Breakdown, by Application
    - 10.2.3.4.3 Italy: Embolization Coils Market Breakdown, by End User
  - 10.2.3.5 Spain: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.5.1 Spain: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.2.3.5.2 Spain: Embolization Coils Market Breakdown, by Application
    - 10.2.3.5.3 Spain: Embolization Coils Market Breakdown, by End User
  - 10.2.3.6 Rest of Europe: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.6.1 Rest of Europe: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.2.3.6.2 Rest of Europe: Embolization Coils Market Breakdown, by Application
    - 10.2.3.6.3 Rest of Europe: Embolization Coils Market Breakdown, by End User
10.3 Asia Pacific
- 10.3.1 Asia Pacific Embolization Coils Market Overview
- 10.3.2 Asia Pacific: Embolization Coils Market - Revenue, 2021-2031 (US$ Million)
  - 10.3.2.1 Asia Pacific: Embolization Coils Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.3.2.2 Asia Pacific: Embolization Coils Market - Revenue and Forecast Analysis - by Application
  - 10.3.2.3 Asia Pacific: Embolization Coils Market - Revenue and Forecast Analysis - by End User
- 10.3.3 Asia Pacific: Embolization Coils Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.1.1 China: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.3.3.1.2 China: Embolization Coils Market Breakdown, by Application
    - 10.3.3.1.3 China: Embolization Coils Market Breakdown, by End User
  - 10.3.3.2 Japan: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.2.1 Japan: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.3.3.2.2 Japan: Embolization Coils Market Breakdown, by Application
    - 10.3.3.2.3 Japan: Embolization Coils Market Breakdown, by End User
  - 10.3.3.3 India: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.3.1 India: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.3.3.3.2 India: Embolization Coils Market Breakdown, by Application
    - 10.3.3.3.3 India: Embolization Coils Market Breakdown, by End User
  - 10.3.3.4 Australia: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.4.1 Australia: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.3.3.4.2 Australia: Embolization Coils Market Breakdown, by Application
    - 10.3.3.4.3 Australia: Embolization Coils Market Breakdown, by End User
  - 10.3.3.5 South Korea: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.5.1 South Korea: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.3.3.5.2 South Korea: Embolization Coils Market Breakdown, by Application
    - 10.3.3.5.3 South Korea: Embolization Coils Market Breakdown, by End User
  - 10.3.3.6 Rest of APAC: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.6.1 Rest of APAC: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.3.3.6.2 Rest of APAC: Embolization Coils Market Breakdown, by Application
    - 10.3.3.6.3 Rest of APAC: Embolization Coils Market Breakdown, by End User
10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Embolization Coils Market Overview
- 10.4.2 Middle East and Africa: Embolization Coils Market - Revenue, 2021-2031 (US$ Million)
  - 10.4.2.1 Middle East and Africa: Embolization Coils Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.4.2.2 Middle East and Africa: Embolization Coils Market - Revenue and Forecast Analysis - by Application
  - 10.4.2.3 Middle East and Africa: Embolization Coils Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Middle East and Africa: Embolization Coils Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 Saudi Arabia: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.1.1 Saudi Arabia: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.4.3.1.2 Saudi Arabia: Embolization Coils Market Breakdown, by Application
    - 10.4.3.1.3 Saudi Arabia: Embolization Coils Market Breakdown, by End User
  - 10.4.3.2 South Africa: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.2.1 South Africa: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.4.3.2.2 South Africa: Embolization Coils Market Breakdown, by Application
    - 10.4.3.2.3 South Africa: Embolization Coils Market Breakdown, by End User
  - 10.4.3.3 United Arab Emirates: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.3.1 United Arab Emirates: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.4.3.3.2 United Arab Emirates: Embolization Coils Market Breakdown, by Application
    - 10.4.3.3.3 United Arab Emirates: Embolization Coils Market Breakdown, by End User
  - 10.4.3.4 Rest of Middle East and Africa: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.4.1 Rest of Middle East and Africa: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.4.3.4.2 Rest of Middle East and Africa: Embolization Coils Market Breakdown, by Application
    - 10.4.3.4.3 Rest of Middle East and Africa: Embolization Coils Market Breakdown, by End User
10.5 South and Central America
- 10.5.1 South and Central America Embolization Coils Market Overview
- 10.5.2 South and Central America: Embolization Coils Market - Revenue, 2021-2031 (US$ Million)
  - 10.5.2.1 South and Central America: Embolization Coils Market - Revenue and Forecast Analysis - by Embolization Coils
  - 10.5.2.2 South and Central America: Embolization Coils Market - Revenue and Forecast Analysis - by Application
  - 10.5.2.3 South and Central America: Embolization Coils Market - Revenue and Forecast Analysis - by End User
- 10.5.3 South and Central America: Embolization Coils Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.1.1 Brazil: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.5.3.1.2 Brazil: Embolization Coils Market Breakdown, by Application
    - 10.5.3.1.3 Brazil: Embolization Coils Market Breakdown, by End User
  - 10.5.3.2 Argentina: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.2.1 Argentina: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.5.3.2.2 Argentina: Embolization Coils Market Breakdown, by Application
    - 10.5.3.2.3 Argentina: Embolization Coils Market Breakdown, by End User
  - 10.5.3.3 Rest of South and Central America: Embolization Coils Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.3.1 Rest of South and Central America: Embolization Coils Market Breakdown, by Embolization Coils
    - 10.5.3.3.2 Rest of South and Central America: Embolization Coils Market Breakdown, by Application
    - 10.5.3.3.3 Rest of South and Central America: Embolization Coils Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Market Share Analysis, 2024

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Merger and Acquisition
12.4 Other Developments

13. Company Profiles

13.1 Medtronic Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Cook Medical Holdings LLC
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Stryker Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Boston Scientific Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Terumo Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 NeuroSafe Medical Co. Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Wallaby Medical
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Penumbra Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Balt
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 INVAMED
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 List of Abbreviations